Breaking News Instant updates and real-time market news.

PCRX

Pacira

$35.40

-4.45 (-11.17%)

, HRTX

Heron Therapeutics

$39.55

8.85 (28.83%)

15:42
06/21/18
06/21
15:42
06/21/18
15:42

Pacira's Exparel may face greater threat from Heron drug, says BMO Capital

BMO Capital analyst Gary Nachman said the newly released Phase 2b data for Heron Therapeutics' (HRTX) HTX-011 in post-surgical pain support a "very solid profile" for the drug, which he thinks will eventually likely be a "viable competitor" to Pacira's (PCRX) Exparel. Given the new data, a more cautious long-term outlook for Exparel may be warranted, contends Nachman, who keeps a Market Perform rating on Pacira shares. In late day trading, Heron shares are up 29% to $39.70, while Pacira has fallen 12% to $34.98.

PCRX

Pacira

$35.40

-4.45 (-11.17%)

HRTX

Heron Therapeutics

$39.55

8.85 (28.83%)

  • 21

    Jun

  • 26

    Jun

  • 27

    Jun

PCRX Pacira
$35.40

-4.45 (-11.17%)

04/23/18
CANT
04/23/18
NO CHANGE
Target $40
CANT
Overweight
Doctor call supports Cantor's positive thesis on Heron Therapeutics
After hosting a conference call with two physicians to better understand how HTX-011 will fit into the post-operative pain market, Cantor Fitzgerald analyst Louise Chen reiterates an Overweight rating on Heron Therapeutics (HRTX) with a $40 price target. Both physicians do not see Pacira Pharmaceuticals' (PCRX) Exparel being used anymore if HTX-011 is approved, Chen tells investors in a research note. The doctors believe that HTX-011 is a better drug that is likely to be priced lower than Exparel, the analyst points out. Chen says the call supports her positive thesis on Heron.
05/03/18
HCWC
05/03/18
NO CHANGE
Target $48
HCWC
Buy
Pacira being conservative with no guidance raise, says H.C. Wainwright
Pacira Pharmaceuticals this morning posted solid Q1 Exparel sales of $74M, just ahead of the Street's $73.1M estimate and up over 9% year-on-year, H.C. Wainwright analyst Oren Livnat tells investors in a research note. He found it important that management highlighted strong intra-quarter growth trends with 6% growth in January accelerating to 15% in March. The analyst believes, however, that investors are concerned with no Exparel guidance increase and "confusing potential near-term Exparel reimbursement developments, or lack thereof." Livnat believes management is being conservative with the outlook and reiterates a Buy rating on Pacira with a $48 price target. The stock in midday trading is down 4% to $32.95.
05/04/18
JMPS
05/04/18
NO CHANGE
Target $56
JMPS
Outperform
Pacira price target lowered to $56 from $65 at JMP Securities
JMP Securities analyst Donald Ellis noted that Pacira Pharmaceuticals reported Q1 earnings that were in-line with consensus and the company reiterated FY18 Exparel sales guidance. He lowered his price target on Pacira to $56 from $65 to account for his updated peer PEG ratios. Ellis maintains an Outperform rating on Pacira, stating that he believes the combination of the DPS partnership, scrutiny against opioids and recent approvals are contributing to the acceleration in Exparel sales.
06/06/18
JEFF
06/06/18
NO CHANGE
Target $49
JEFF
Buy
Pacira sales inflection may 'finally be underway,' says Jefferies
After hosting an investor dinner with Pacira Pharmaceuticals (PCRX) CEO Dave Stack, Jefferies analyst David Steinberg believes a "meaningful sales inflection for Exparel may finally be underway." Management is increasingly confident that an Exparel sales inflection, driven by the Johnson & Johnson (JNJ) partnership and expanded nerve block indication, is underway, Steinberg tells investors in a research note. Further, he believes a "potentially significant" Exparel rest-of-work partnership is likely to be announced prior to the end of 2018. The analyst keeps a Buy rating on Pacira Pharmaceuticals with a $49 price target.
HRTX Heron Therapeutics
$39.55

8.85 (28.83%)

06/21/18
EVER
06/21/18
NO CHANGE
Target $80
EVER
Outperform
Heron Therapeutics price target raised to $80 from $56 at Evercore ISI
Evercore ISI analyst Josh Schimmer raised his price target on Heron Therapeutics to $80 from $56 after the company announced positive topline results from two Phase 2b studies of HTX-011.
06/21/18
06/21/18
NO CHANGE
Target $80

Outperform
Heron Therapeutics price target raised to $80 on positive HTX-011 results at Evercore ISI
As previously reported, Evercore ISI analyst Josh Schimmer raised his price target for Heron Therapeutics to $80 from $56 after the company reported data from its two Phase 2b studies of HTX-011 for prevention of post-op pain following total knee arthroplasty and breast augmentation. The analyst notes that these were primarily for procuring a broad post-surgical label based on the highly compelling Phase 3 studies of the product in bunionectomy and hernia repair by demonstrating safety and predictable PK. HTX-011 not only demonstrated the required safety and PK profile to support a broad label, but the results showed clear clinical benefit over both placebo and bupivacaine, Schimmer adds. The analyst reiterates an Outperform rating on the shares.
06/21/18
CANT
06/21/18
NO CHANGE
Target $40
CANT
Overweight
Cantor has $59 per share 'bull case scenario' for Heron Therapeutics
Cantor Fitzgerald analyst Louise Chen says the positive data announced this morning by Heron Therapeutics will support the new drug application filing for HTX-011 and expand the commercial opportunity for the drug. The analyst continues to believe that the peak sales potential for HTX-011 is being underappreciated. She has a $40 price target on the shares with a $59 "bull case scenario." Chen keeps an Overweight rating on Heron Therapeutics. The stock in morning trading is up 30% to $39.82.
06/21/18
NEED
06/21/18
NO CHANGE
Target $66
NEED
Buy
Heron Therapeutics price target raised to $66 from $42 at Needham
Needham analyst Serge Belanger raised his price target on Heron Therapeutics to $66 after the company announced positive topline results from two Phase 2b studies of HTX-011 for prevention of post-op pain following total knee arthroplasty and breast augmentation.

TODAY'S FREE FLY STORIES

DIS

Disney

$110.81

0.51 (0.46%)

12:10
07/18/18
07/18
12:10
07/18/18
12:10
Options
Disney calls outpace puts more than 3:1 as shares advance »

Disney calls outpace puts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 07

    Aug

12:10
07/18/18
07/18
12:10
07/18/18
12:10
General news
Treasury Option Action: bullish risk reversals in 5-year futures »

Treasury Option Action:…

12:10
07/18/18
07/18
12:10
07/18/18
12:10
General news
Powell on low wage growth: the Fed looks at a range of wages »

Powell on low wage…

MD

Mednax

$43.78

-0.27 (-0.61%)

, EVHC

Envision Healthcare

$44.79

-0.065 (-0.14%)

12:07
07/18/18
07/18
12:07
07/18/18
12:07
Periodicals
Chanos reiterating short calls on Mednax, Envision Healthcare at CNBC event »

Kynikos Associates…

MD

Mednax

$43.78

-0.27 (-0.61%)

EVHC

Envision Healthcare

$44.79

-0.065 (-0.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UTX

United Technologies

$132.25

1.54 (1.18%)

12:05
07/18/18
07/18
12:05
07/18/18
12:05
Hot Stocks
U.S. start-up airline ordres 60 A220 aircraft, powered by P&W GTF engines »

Pratt & Whitney, a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Jul

TECD

Tech Data

$85.99

0.7 (0.82%)

, MSFT

Microsoft

$105.21

-0.79 (-0.75%)

12:05
07/18/18
07/18
12:05
07/18/18
12:05
Hot Stocks
Tech Data signs distribution agreement with Advantech »

Tech Data (TECD)…

TECD

Tech Data

$85.99

0.7 (0.82%)

MSFT

Microsoft

$105.21

-0.79 (-0.75%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

  • 08

    Aug

  • 08

    Aug

  • 04

    Sep

GOOGL

Alphabet Class A

$1,212.96

-0.69 (-0.06%)

, GOOG

Alphabet

$1,197.15

-1.66 (-0.14%)

12:04
07/18/18
07/18
12:04
07/18/18
12:04
General news
Fly Intel: Wall Street's top stories at midday »

Stocks opened with minor…

GOOGL

Alphabet Class A

$1,212.96

-0.69 (-0.06%)

GOOG

Alphabet

$1,197.15

-1.66 (-0.14%)

AMZN

Amazon.com

$1,843.77

-0.23 (-0.01%)

AAPL

Apple

$190.21

-1.34 (-0.70%)

MS

Morgan Stanley

$50.70

1.5 (3.05%)

UAL

United Continental

$79.11

6.45 (8.88%)

CSX

CSX

$68.30

3.88 (6.02%)

ABT

Abbott

$64.56

1.72 (2.74%)

SAH

Sonic Automotive

$19.00

-1.45 (-7.09%)

HCSG

Healthcare Services

$37.90

-4.485 (-10.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 18

    Jul

  • 18

    Jul

  • 18

    Jul

  • 18

    Jul

  • 23

    Jul

  • 23

    Jul

  • 26

    Jul

  • 27

    Jul

  • 31

    Jul

  • 08

    Aug

  • 16

    Aug

  • 26

    Aug

  • 18

    Sep

  • 28

    Oct

GS

Goldman Sachs

$231.70

0.74 (0.32%)

12:03
07/18/18
07/18
12:03
07/18/18
12:03
Upgrade
Goldman Sachs rating change  »

Goldman Sachs upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OKTA

Okta

$55.70

-0.11 (-0.20%)

12:02
07/18/18
07/18
12:02
07/18/18
12:02
Hot Stocks
Okta acquires ScaleFT, terms not disclosed »

Okta announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SKY

Skyline

$29.61

-2.04 (-6.45%)

12:00
07/18/18
07/18
12:00
07/18/18
12:00
Hot Stocks
Skyline falls -6.5% »

Skyline is down -6.5%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SAH

Sonic Automotive

$18.90

-1.55 (-7.58%)

12:00
07/18/18
07/18
12:00
07/18/18
12:00
Hot Stocks
Sonic Automotive falls -7.1% »

Sonic Automotive is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Jul

NCS

NCI Building

$18.40

-2.3 (-11.11%)

12:00
07/18/18
07/18
12:00
07/18/18
12:00
Hot Stocks
NCI Building falls -11.1% »

NCI Building is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UAL

United Continental

$78.93

6.27 (8.63%)

12:00
07/18/18
07/18
12:00
07/18/18
12:00
Hot Stocks
United Continental rises 8.5% »

United Continental is up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

GWW

Grainger

$336.30

31.09 (10.19%)

12:00
07/18/18
07/18
12:00
07/18/18
12:00
Hot Stocks
Grainger rises 10.2% »

Grainger is up 10.2%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

ETFC

E-Trade

$63.09

1.95 (3.19%)

12:00
07/18/18
07/18
12:00
07/18/18
12:00
Options
Heavy call volume as E*Trade shares rally 3% ahead of results »

Heavy call volume as…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

EBF

Ennis

$22.85

3 (15.11%)

12:00
07/18/18
07/18
12:00
07/18/18
12:00
Hot Stocks
Ennis rises 15.4% »

Ennis is up 15.4%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

MA

MasterCard

$206.34

0.03 (0.01%)

, V

Visa

$140.21

0.53 (0.38%)

11:59
07/18/18
07/18
11:59
07/18/18
11:59
Earnings
On The Fly: What to watch in credit card space earnings reports »

American Express (AXP),…

MA

MasterCard

$206.34

0.03 (0.01%)

V

Visa

$140.21

0.53 (0.38%)

AXP

American Express

$102.50

1.36 (1.34%)

AMZN

Amazon.com

$1,845.38

1.38 (0.07%)

PYPL

PayPal

$88.34

-0.25 (-0.28%)

FDC

First Data

$22.78

0.23 (1.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 18

    Jul

  • 25

    Jul

  • 26

    Jul

  • 26

    Jul

  • 30

    Jul

  • 06

    Aug

  • 08

    Aug

  • 15

    Aug

  • 16

    Aug

  • 16

    Aug

11:55
07/18/18
07/18
11:55
07/18/18
11:55
Conference/Events
Wolfe Research airlines analyst to hold a luncheon meeting »

Airlines Analyst Keay…

MKL

Markel

$1,140.97

8.97 (0.79%)

11:53
07/18/18
07/18
11:53
07/18/18
11:53
Hot Stocks
Markel gains license for German insurance company »

Markel announced that it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HUN

Huntsman

$30.86

0.27 (0.88%)

11:53
07/18/18
07/18
11:53
07/18/18
11:53
Periodicals
Huntsman mentioned positively by Atlantic's Roepers »

Atlantic Investment…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    Jul

CIEN

Ciena

$26.36

-0.59 (-2.19%)

11:50
07/18/18
07/18
11:50
07/18/18
11:50
Recommendations
Ciena analyst commentary  »

MKM Partners refutes bear…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Sep

HLT

Hilton

$82.70

1.64 (2.02%)

11:50
07/18/18
07/18
11:50
07/18/18
11:50
Options
Bullish option play in Hilton Worlwide as shares rally ahead of earnings »

Bullish option play in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Jul

11:50
07/18/18
07/18
11:50
07/18/18
11:50
General news
U.S. Commerce Department is mulling a uranium probe »

U.S. Commerce Department…

GE

General Electric

$13.77

0.07 (0.51%)

, TDC

Teradata

$43.08

-0.26 (-0.60%)

11:47
07/18/18
07/18
11:47
07/18/18
11:47
Hot Stocks
GE Aviation, Teradata expand partnership »

GE Aviation (GE) and…

GE

General Electric

$13.77

0.07 (0.51%)

TDC

Teradata

$43.08

-0.26 (-0.60%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 02

    Aug

  • 16

    Aug

  • 21

    Aug

MLCO

Melco Resorts & Entertainment

$24.09

-0.53 (-2.15%)

11:45
07/18/18
07/18
11:45
07/18/18
11:45
Options
Melco Resorts call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.